John Bridgen, VP, Strategy for PD Cardiology at INVERNESS MEDICAL INNOVATIONS INC (IMA), sold 13,430 shares at $59.18 ($795K) on 2007-11-20, disclosed to the SEC on 2007-11-21.
Open-market sale of $795k IMA by VP, Strategy for PD Cardiology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ALR | SELL | 2015-03-19 | $1.2M | — | Filing → |
| ALR | SELL | 2014-12-12 | $1.9M | — | Filing → |
| ALR | SELL | 2012-08-09 | $222K | — | Filing → |